Daniel C.

Director Quality Assurance, Qp @Viatris

Canterbury, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Oct 2021 — Present

Director Quality Assurance, Qp @Viatris

View department →

Canterbury, GB

Head of Quality, MGRGLeading the Quality oversight of R&D projects and GMP/GDP Quality oversight for the provision of IMP to clinical studies across the Viatris network globally. Responsible for generic and innovative products under development, covering an extensive range of therapeutic areas/products types/dosage forms; from Respiratory, Biologics, Steriles, Dermatologicals, OSD, to Combination Products and ATMPs (Gene Therapies).Viatris is a new kind of global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. We are on an exciting new journey to empower people worldwide to live healthier at every stage of life. Our global portfolio includes best-in-class, iconic brand name products as well as global key brands; generics, including branded and complex generics; biosimilars; and over-the-counter offerings across a wide range of therapeutic areas. We are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.Viatris has one of the strongest global commercial infrastructures in the industry, with a balanced reach across North America, Europe, the Asia Pacific region and emerging markets. Our high quality global manufacturing, scientific excellence and vast supply chain network mean we are uniquely positioned to improve access to medicine for patients worldwide.

EDUCATION

2005 — 2007

University of Greenwich

MSc, Pharmaceutical Sciences

1998 — 2001

University of Southampton

BSc, Physics

2018 — 2019

University of Strathclyde

PGDip, Pharmaceutical Quality and Good Manufacturing Practice

2002 — 2004

University of Greenwich

HNC, Chemistry

SKILLS

Technology TransferChromatographyGmpFormulationDrug DiscoveryClinical TrialsMethod DevelopmentHplcChemistryUvAnalytical ChemistryDrug DevelopmentAnalytical TechniquesGas ChromatographyLimsLc-MsDissolutionPharmaceutical IndustrySopUv/VisIn-Vitro BioequivalenceValidationCleaning ValidationGlp

ABOUT DANIEL C.

I am a senior Quality leader with 25+ years of global pharmaceutical industry experience across the full product lifecycle - from early clinical development through market authorisation, technology transfer, and commercial operations. I have supported a broad range of drug products including biologics, liquids, oral solid dose, inhalation and advanced therapies, enabling robust and compliant inspection-readiness.Throughout my career I have built, led and developed high-performing teams, including senior quality professionals and Qualified Persons, embedding a culture of accountability, continuous improvement, and patient focus, whilst driving Quality strategy globally. I am able to partner closely with senior/executive leadership and cross-functional stakeholders to align Quality strategy with business objectives and accelerated development timelines, to ultimately support sustainable growth.Recognised for translating regional regulatory and compliance expectations into pragmatic, risk-based solutions, I bring a strong track record in global collaboration, complex program leadership, and delivery of strategic initiatives that strengthen Quality systems and support successful product approvals and commercialisation.Professional Qualifications- Certified as eligible Qualified Person under the permanent provisions of EU Directives 2001/83/EC and 2001/82/EC (certificate number PDO1033)- Member of the Royal Society of Chemistry (MRSC)- Chartered Chemist (CChem)

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Daniel C. — Director Quality Assurance, Qp at Viatris in Canterbury, GB | Unifers